Astrazeneca PLC (AZN)
- Sector
- Pharmaceuticals
- Last price
- $184.38
- As of
Kresmion compiles this page from AZN's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
ASTRAZENECA PLC (AZN): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-11-02.
See the full AZN dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for AZN on one page. Preview it with sample data, then open it live with a free account.
Preview the AZN dossierActive events for AZN
- high13F: funds added
4 tracked funds increased AZN this 2026Q2, institutional consensus
- medium13F: new position
CITADEL ADVISORS LLC new position in AZN
- high13F: large increase
Point72 Asset Management, L.P. added +3379% to AZN (2026Q2)
- high13F: large reduction
MILLENNIUM MANAGEMENT LLC cut 90% of AZN (2026Q2)
- high13F: large reduction
MILLENNIUM MANAGEMENT LLC cut 55% of AZN (2026Q2)
FREE, NO ACCOUNT
Every event on AZN, as it fires
You are seeing 5 of 14 events recorded on AZN since 2026-06-14.
The five above landed across 2 days. The other 9 were recorded on 2 other days. 11 of the 14 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
AZN positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| D. E. Shaw & Co., Inc. FundCUSIP G0593M107 · 2026Q2 | $207.6M | 0.13% |
| CITADEL ADVISORS LLC FundCUSIP G0593M107 · 2026Q2 | $183.9M | 0.11% |
| Point72 Asset Management, L.P. FundCUSIP G0593M107 · 2026Q2 | $134.9M | 0.21% |
| MILLENNIUM MANAGEMENT LLC FundCUSIP G0593M107 · 2026Q2 | $110.3M | 0.07% |
| TWO SIGMA INVESTMENTS, LP FundCUSIP G0593M107 · 2026Q2 | $62.4M | 0.05% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, AZN
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
More data on AZN
AZN against its peers
AZN's operating margin of 23.4% ranks in the 74th percentile of 16 Pharmaceuticals sub-industry peers, fiscal periods ending between 2025-12-28 and 2025-12-31.
| Metric | AZN | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 58.7B USD | 5.2B USD | 80 | 22 |
| Revenue YoY | 8.6% | n/a | n/a | 3 |
| Gross margin | 81.9% | 72.4% | 78 | 15 |
| Operating margin | 23.4% | 10.5% | 74 | 16 |
| Net margin | 17.4% | 8.9% | 65 | 23 |
| Return on equity | 21.0% | 15.4% | 60 | 23 |
| P / E | n/a | 21.2x | n/a | 13 |
| 1 year | 5.1% | 27.0% | 33 | 25 |
Peers (25): NVS, MRK, NVO, PFE, BMY, JNJ, GSK, LLY, TEVA, ZTS, VTRS, JAZZ, CORT, AMRX, AXSM, LQDA, AMLX, OGN, TARS, BHC, XERS, HRMY, TRVI, SUPN, ANIP. Fiscal periods ending between 2025-12-28 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (AZN: 20-F), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in AZN on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on AZN in the last 180 days.
Upstream: SEC EDGAR filings for AZN
Kresmion, "ASTRAZENECA PLC (AZN) institutional holdings and SEC filings", data as of 2026-11-02, https://kresmion.com/research/AZN. Upstream data: SEC EDGAR filings for AZN.
Link to this data (HTML):
<a href="https://kresmion.com/research/AZN">ASTRAZENECA PLC (AZN) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow AZN on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to AZN for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.